There are 33 resources available
1st line chemotherapy for advanced NSCLC
Presenter: D. Planchard, FR
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
1st line Immune-checkpoint blockade for advanced NSCLC
Presenter: L. Paz-Ares, ES
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
2nd line treatment for advanced NSCLC
Presenter: M. Reck, DE
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
Treatment of EGFR mutant advanced NSCLC
Presenter: R. Califano, UK
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
Treatment of ALK and ROS1 positive advanced NSCLC
Presenter: F. Blackhall, UK
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
Treatment of KRAS mutant advanced NSCLC
Presenter: C. Lindsay, UK
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
Beyond EGFR, ALK, ROS1 and KRAS: Novel molecularly driven targeted therapies in NSCLC
Presenter: S. Ekman, SE
Session: SESSION 4 - Advanced NSCLC
Resources:
Slides
Webcast
Systemic treatment of mesothelioma
Presenter: P. Baas, NL
Session: SESSION 5 - Management of mesothelioma, oligometastatic NSCLC and brain metastases
Resources:
Slides
Webcast
Treatment of oligometastatic NSCLC
Presenter: A-M. Dingemans, NL
Session: SESSION 5 - Management of mesothelioma, oligometastatic NSCLC and brain metastases
Resources:
Slides
Webcast
Radical treatment of brain metastases: The importance of a neuro-oncology multi-disciplinary approach
Presenter: C. McBain, UK
Session: SESSION 5 - Management of mesothelioma, oligometastatic NSCLC and brain metastases
Resources:
Slides